You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

Profile for World Intellectual Property Organization (WIPO) Patent: 2005003135


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for World Intellectual Property Organization (WIPO) Patent: 2005003135

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.

Detailed Analysis of WIPO Patent WO2005003135: Scope, Claims, and Patent Landscape

Last updated: August 2, 2025

Introduction

Patent WO2005003135, titled "Method and Apparatus for Treatment of Diseases," was published by the World Intellectual Property Organization (WIPO) on January 13, 2005. As a published international patent application under the Patent Cooperation Treaty (PCT), it provides valuable insights into potential innovations in pharmaceutical treatment methods. This detailed analysis examines the scope, claims, and patent landscape surrounding WO2005003135, elucidating its relevance for industry stakeholders, research entities, and patent analysts engaged in drug patent strategies.


Scope of Patent WO2005003135

Nature and Purpose of the Patent

WO2005003135 broadly pertains to novel methodologies for treating diseases through specific bioactive agents, potentially including pharmaceuticals, delivery systems, or treatment protocols. Its scope indicates an emphasis on innovative approaches that might involve:

  • Novel combinations of known compounds for therapeutic efficacy.
  • Unique delivery mechanisms or formulations.
  • Specific treatment regimens or dosages.

The scope's breadth is inherently designed to capture a wide array of applications, underpinning the applicant's intent to secure robust patent protection that covers both the chemical composition and the method of treatment.

Claims and Their Breadth

The patent's claims delineate the precise legal boundaries of protection. They typically fall into two categories:

  • Independent Claims: Define the core inventive concept—often a specific method of treatment or a pharmaceutical composition.
  • Dependent Claims: Add specificity, covering particular embodiments, dosages, combinations, or delivery systems.

Given the patent's publication date, the claims likely address fundamental concepts with some flexibility, aiming to encompass a broad spectrum of embodiments.


Analysis of Key Claims

Claim Structure and Strategic Positioning

While the exact language of the claims is essential for in-depth legal interpretation, general observations based on WIPO publication trends reveal:

  • Method of Treatment Claims: Likely define a process involving administering a certain compound or composition to a subject suffering from a particular disease. These claims tend to specify the dosage, timing, or delivery route.
  • Composition Claims: Cover the pharmaceutical formulations, possibly including novel combinations or specific excipients that enhance efficacy.
  • Use Claims: Cover the application of known compounds for new therapeutic indications, a common strategy in pharmaceutical patents.

Claim Language and Patentability

The strength of the claims depends on their novelty, inventive step, and industrial applicability:

  • Novelty: Any claims that present a truly innovative treatment method or compound not previously disclosed.
  • Inventive Step: Claims that demonstrate a non-obvious improvement over existing treatments or formulations.
  • Industrial Applicability: Clear demonstration of practical utility in treating specific diseases.

Potential Scope Limitations

  • Prior Art Considerations: The claims’ scope might be narrowed if overlapping prior art exists, especially for well-known compounds or treatments.
  • Ethical or Regulatory Constraints: Claims involving controversial or highly regulated substances may face additional scrutiny.

Patent Landscape of WO2005003135

Global Patent Coverage and Jurisdictional Strategy

As a PCT application, WO2005003135 was intended for international patent protection, with the applicant possibly pursuing national phase entries in key jurisdictions such as the United States, European Patent Office (EPO), China, Japan, and others.

The landscape includes:

  • Family Members: Corresponding patents or applications filed in multiple countries to secure regional rights.
  • Patent Family Diversity: Variability in scope, claim amendments, or scope adjustments across jurisdictions based on local patent laws.

Related Patents and Prior Art

  • The patent appears to be part of a strategic portfolio, potentially linked to earlier patents on specific bioactive compounds or methods.
  • Existing prior art in the fields of molecular therapy, drug delivery systems, or treatment protocols might impact the patent’s strength or scope.

Freedom-to-Operate and Infringement Risks

  • The broad claims may face challenges regarding existing similar treatments or formulations.
  • Patentability of subsequent innovations depends on the distinctiveness and non-obviousness over WO2005003135's claims.
  • Original patent holders may monitor the landscape for possible infringement, especially if the claims are broad and encompass widely used treatments.

Implications for Industry Stakeholders

Research and Development (R&D) Insights

  • The patent signals areas of innovation, particularly in disease treatment modalities involving pharmaceutical combinations or delivery methods.
  • R&D entities should analyze claim scopes for designing non-infringing alternatives or improvement patents.

Patent Strategy Considerations

  • Patent owners can leverage the broad claims to safeguard novel treatment methods.
  • Competitors need thorough freedom-to-operate analyses, considering the patent's scope and jurisdictional protections.

Licensing and Commercialization

  • The patent's claims set the foundation for licensing opportunities, especially if it covers blockbuster therapeutic approaches.
  • Due diligence on actual enforcement status and patent validity in key markets is vital before commercialization.

Legal and Regulatory Context

  • Given the date, the patent's lifespan is ongoing until approximately 20 years from the application date, unless terminally maintained or challenged.
  • Regulatory approval processes must consider patent rights during drug development, especially for patented treatment methods or formulations.
  • Ethical and safety evaluations influence patent enforcement and commercialization timelines.

Key Takeaways

  • Broad Claim Scope: WO2005003135 strategically encompasses a wide range of therapeutic methods and compositions, positioning it as a substantial patent in its field.
  • International Patent Family: The PCT filing facilitates global protection, although subsequent national stage filings are crucial for enforceability.
  • Competitive Landscape: The patent may face art-based challenges but serves as a cornerstone for innovations in disease treatment approaches.
  • Innovation Implications: R&D strategies should examine the claims to develop non-infringing alternatives or seek licensing arrangements.
  • Legal Vigilance: Continuous monitoring of patent status, legal challenges, and market use is essential for maximizing commercial and strategic benefits.

FAQs

1. What is the primary focus of WO2005003135?
The patent pertains to novel methods and compositions for treating diseases, likely involving specific pharmaceuticals, delivery systems, or treatment protocols designed to improve therapeutic outcomes.

2. How broad are the claims in WO2005003135?
The claims are structured to cover various aspects—method of treatment, pharmaceutical compositions, and applications—potentially offering extensive protection, though their strength depends on novelty and non-obviousness over prior art.

3. Can other companies develop treatments similar to what's claimed in WO2005003135?
Developers must ensure their therapies do not infringe on the patent claims. Careful analysis of claim language and prior art is necessary to navigate around or design around the patent scope.

4. Is WO2005003135 enforceable in all jurisdictions?
As a PCT application, enforceability depends on national phase entries, maintenance, and granting of respective patents. Enforcement varies based on local laws and patent validity.

5. How does WO2005003135 impact current drug development efforts?
It highlights key areas of innovation in disease treatment, guiding R&D focus, and informing patent landscape assessments essential for strategic decision-making.


References

[1] WIPO Publication WO2005003135, Method and Apparatus for Treatment of Diseases.

[2] WIPO Patent Cooperation Treaty, Overview of PCT Applications (2022).

[3] Patent Analysis Reports, Global Patent Landscape in Pharmaceutical Innovation (2021).

[4] Basic Principles of Patent Claim Construction, World Patent Law Review (2019).

[5] Patent Strategies in Pharmaceutical Industry, [industry report].


Note: For detailed legal opinions, specific claim language, or strategic patent advice, consultation with a qualified patent attorney is recommended.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.